In breast cancer cells, lncRNA CYTOR binds to miR-125-5p, downregulating its levels and promoting the expression of serum response factor (SRF), thereby increasing resistance to tamoxifen (TAM) (Liu et al., 2020b). Here, SRF is linked to breast carcinoma.